We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

129 hedge funds and large institutions have $628M invested in Arena Pharmaceuticals Inc in 2014 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 33 increasing their positions, 44 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less capital invested

Capital invested by funds: $645M → $628M (-$16.9M)

10% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 21

2% less funds holding

Funds holding: 131 → 129 (-2)

25% less repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 44

47% less call options, than puts

Call options by funds: $22.8M | Put options by funds: $43.1M

Holders
129
Holders Change
-2
Holders Change %
-1.53%
% of All Funds
3.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
33
Reduced
44
Closed
21
Calls
$22.8M
Puts
$43.1M
Net Calls
-$20.2M
Net Calls Change
+$4.67M

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$19.9M
2
Norges Bank
Norges Bank
Norway
+$13.7M
3
Morgan Stanley
Morgan Stanley
New York
+$8.89M
4
Group One Trading
Group One Trading
Illinois
+$4.34M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.6M

Top Sellers

Rank Fund Capital Flow
1
BA
BlackRock Advisors
Delaware
-$6.18M
2
BFA
BlackRock Fund Advisors
California
-$4.12M
3
Goldman Sachs
Goldman Sachs
New York
-$3.68M
4
State Street
State Street
Massachusetts
-$3.57M
5
Bank of America
Bank of America
North Carolina
-$3.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
AA
126
Apriem Advisors
California
$1K – – –
HRIA
127
Haberer Registered Investment Advisor
Ohio
$1K – – –
WT
128
Whittier Trust
California
$1K – – –
FCCM
129
First City Capital Management
Georgia
$586 – – –
SB
130
Suntrust Banks
Georgia
– -$1.16M -18,501 Closed
CBOA
131
Commonwealth Bank of Australia
Australia
– -$1.07M -16,987 Closed
TMAM
132
Tokio Marine Asset Management
Japan
– -$625K -9,920 Closed
ACI
133
Alpha Cubed Investments
California
– -$320K -5,080 Closed
Two Sigma Investments
134
Two Sigma Investments
New York
– -$271K -4,302 Closed
HNB
135
Huntington National Bank
Ohio
– -$252K -4,000 Closed
WMSA
136
Weiss Multi-Strategy Advisers
New York
– -$214K -3,404 Closed
RJA
137
Raymond James & Associates
Florida
– -$202K -3,205 Closed
N
138
Natixis
France
– -$171K -2,720 Closed
PPA
139
Parametric Portfolio Associates
Washington
– -$154K -2,447 Closed
UCFA
140
United Capital Financial Advisors
Texas
– -$146K -2,310 Closed
Comerica Bank
141
Comerica Bank
Texas
– -$127K -2,022 Closed
BAS
142
Brown Advisory Securities
Maryland
– -$126K -2,000 Closed
Capital Fund Management (CFM)
143
Capital Fund Management (CFM)
France
– -$100K -1,590 Closed
SSWM
144
Sheets Smith Wealth Management
North Carolina
– -$89K -1,408 Closed
SGH
145
Schonfeld Group Holdings
New York
– -$67K -1,057 Closed
US Bancorp
146
US Bancorp
Minnesota
– -$40K -630 Closed
BJ
147
BlackRock Japan
Japan
– -$20K -325 Closed
SFSIG
148
San Francisco Sentry Investment Group
California
– -$8K -120 Closed
Envestnet Asset Management
149
Envestnet Asset Management
Illinois
– -$3K -50 Closed
VIA
150
Vantage Investment Advisors
Pennsylvania
– -$1K -10 Closed
2 3 4 5
6

ARNA Hedge Fund Activity: Q2 2014 in Review

129 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q2 2014, worth a combined $628M — down 2.6% from $645M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of ARNA and 19 opened new positions — a net loss of 2 holders — while 44 trimmed existing stakes and 33 added.

The largest buyer was Deerfield Management, adding an estimated $19.9M. The largest seller was BlackRock Advisors, cutting an estimated $6.18M.

  • 129 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q2 2014, down from 131 in Q1 2014.
  • Funds reported $628M of Arena Pharmaceuticals Inc stock for Q2 2014, down 2.6% quarter-over-quarter.
  • 19 funds opened new Arena Pharmaceuticals Inc positions in Q2 2014 and 21 closed out, a net change of -2 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q2 2014 was Deerfield Management, an estimated $19.9M added.
  • The largest Arena Pharmaceuticals Inc seller in Q2 2014 was BlackRock Advisors, an estimated $6.18M sold.

Based on aggregated 13F filings for Q2 2014.